Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with weight management and activates hormone receptors. Potential side effects include gastrointestinal issues, pancreatitis, hypoglycemia, and gallbladder problems. Individuals with specific health conditions should consult a doctor before use. Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with weight management and activates hormone receptors. Potential side effects include gastrointestinal issues, pancreatitis, hypoglycemia, and gallbladder problems. Individuals with specific health conditions should consult a doctor before use. Health and Fitness, Health Tips, Exercises & Workout Tips, Diet & Wellness | Times of India Lifestyle
